MIG6 plays a necessary role of in negative feedback regulation of ErbB receptors.
MIG6 suppresses EGFR signaling via kinase inhibition and down-regulation.
MIG6 loss enhances oncogenic ErbB signaling.
MIG6 loss in tumors is a potential biomarker of oncogenic addiction to ErbB signaling.